Large bowel carcinoid tumors

Current Opinion in Gastroenterology

Volumn 23, Issue 1, 2007, Pages 74-78

  Northrop, Jennifer A ^a   Lee, Jeffrey H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinoids; MIBG; Octreotide scanning

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 5 HYDROXYTRYPTOPHAN; CARBON 11; FLUORODEOXYGLUCOSE F 18; INTERFERON; LUTETIUM 177; OCTREOTIDE; PENTETATE INDIUM IN 111; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; YTTRIUM 90;

APPENDIX TUMOR; CANCER INCIDENCE; CARCINOID; CARCINOID SYNDROME; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EVALUATION; HEMICOLECTOMY; HUMAN; IMAGE ANALYSIS; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RECTUM TUMOR; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; TACHYPHYLAXIS;

CARCINOID TUMOR; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, LARGE;

EID: 33845291086     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328011752a     Document Type: Review

References (25)

1. Schnirer I, Yao J, Ajani J. Carcinoid. Acta Oncol 2003; 42:672-692.
2. Ahlman H, Nilsson O. The gut as the largest endocrine organ in the body. Ann Oncol 2001; 12 (Suppl 2):S63-S68.
3. Gore R, Berlin J, Mehta U, et al. GI carcinoid tumours: appearance of the primary and detecting metastases. Best Pract Res Clin Endocrinol Metab 2005; 19:245-263. Gore et al. provide a comprehensive compilation for the methodology of diagnosis of primary and metastatic carcinoid tumors. The description of the newest radiologic techniques, especially the section on scintigraphy, is particularly significant. This is one of the few articles that discusses these cutting edge and investigational techniques in detail.
4. De Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Pract Res Clin Endocrinol Metab 2005; 19:705-715. This article provides the most inclusive review of the medical therapy available to patients not cured by surgical intervention. In particular, the concise summary of the various studies and their outcomes with chemotherapeutic agents is most relevant.
5. Oberg K, Eriksson B. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumors. Best Pract Res Clin Endocrinol Metab 2005; 19:265-276. Oberg and Eriksson provide an excellent summary of the recent advances made with PET scanning and nuclear agents; in fact, this article was the only one to review the radiolabelled somatostatin analogues employed in tumor-targeted therapy.
6. Maggard M, O'Connell J, Ko C. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240:117-122.
7. Arnold R. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Endocrinol Metab 2005; 19:491-505. This article provides the most thorough historical review of the histologic aspects and nomenclature attributed to carcinoid tumors since their initial description in the late 1800s. Furthermore, the description of the various classifications of carcinoids is more elaborate than in other recent literature. The section on the inherited syndromes associated with gastrointestinal neuroendocrine tumors is also unique to this article.
8. Wallace S, Ajani J, Charnsangavej C, et al. Carcinoid tumors: imaging procedures and interventional radiology. World J Surg 1996; 20:147-156.
9. Habal N, Sims C, Bilchik A. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000; 75:310-316.
10. Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Endocrinol Metab 2005; 19:507-517. Kloppel and Anlauf offer a succinct yet thorough up-to-date summation of the specific behavior and epidemiology of gastrointestinal carcinoids.
11. Shebani K, Souba W, Finkelstein D, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999; 229:815-821.
12. Iimuro Y, Deguchi Y, Ueda Y, et al. Primary hepatic carcinoid tumor with metachronous lymphnode metastasis after long-term follow up. J Gastroenterol Hepatol 2002; 17:1119-1124.
13. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005; 103:1587-1595. This is a comprehensive study detailing the recent trends noted in metastatic and five-year survival rates for carcinoids as reflected by changes in diagnosis and treatment.
14. Horton K, Fishman E. Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms. J Comput Assist Tomogr 2004; 28:106-116.
15. Horton K, Kamel I, Hofmann L, Fishman E. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR Am J Roentgenol 2004; 182:559-567.
16. Szilvas A, Szekely G, Szilvasi I, et al. The importance of follow-up examinations in patients with carcinoid tumor. Hepatogastroenterology 2003; 50:1452-1453.
17. 18F Dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220:373-380.
18. Orlefors H, Sundin A, Garske U, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005; 90:3392-3400.
19. Nikou GC, Lygidakis NJ, Toubanakis C, et al. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Hepatogastroenterology 2005; 52:731-741.
20. Kidd M, Modlin I, Mane S, et al. QRT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease. Ann Surg 2006; 243:273-280.
21. Tonnies H, Toliat MR, Ramel C, et al. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridization. Gut 2001; 48:536-541.
22. Kulke M, Mayer R. Carcinoid tumors. N Engl J Med 1999; 340:858-868.
23. Caplin M, Buscombe J, Hilson A, et al. Carcinoid tumor. Lancet 1998; 352:799-805.
24. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumours. A 31-case French multicentric report. Ann Surg 1997; 225:355-364.
25. Tetzlaff E, Ajani J. Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor. Int J Gastrointest Cancer 2005; 36:55-58.